Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Versatile role of curcumin and its derivatives in lung cancer therapy
Milad Ashrafizadeh, Masoud Najafi, Pooyan Makvandi, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9241-9268
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Kamran Mansouri, Shna Rasoulpoor, Alireza Daneshkhah, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 315
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112563-112563
Open Access | Times Cited: 237
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, et al.
Nano Today (2021) Vol. 38, pp. 101119-101119
Open Access | Times Cited: 201
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 139
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 139
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 136
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 126
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 121
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 115
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli‐Responsive, Toxicity, Immunogenicity, and Clinical Translation
Esmaeel Sharifi, Ashkan Bigham, Satar Yousefiasl, et al.
Advanced Science (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 105
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer
Marzieh Ramezani Farani, Maryam Azarian, Hamid Heydari Sheikh Hossein, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 1305-1318
Open Access | Times Cited: 91
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 75
Carboranes as unique pharmacophores in antitumor medicinal chemistry
Yu Chen, Fukuan Du, Liyao Tang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 400-416
Open Access | Times Cited: 72
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1263-1321
Closed Access | Times Cited: 64
Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications
Harish Bhardwaj, Rajendra Jangde
Next Nanotechnology (2023) Vol. 2, pp. 100013-100013
Open Access | Times Cited: 59
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
Milad Ashrafizadeh, Ali Zarrabi, Sepideh Mirzaei, et al.
Food and Chemical Toxicology (2021) Vol. 157, pp. 112576-112576
Closed Access | Times Cited: 98
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Liyan Yang, Zhonglei Wang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 689-689
Open Access | Times Cited: 90
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1229-1253
Open Access | Times Cited: 61
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Chong Yu, Bo Yang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 6, pp. 397-415
Open Access | Times Cited: 60
Strategies for Improving Bioavailability, Bioactivity, and Physical-Chemical Behavior of Curcumin
Levente Zsolt Racz, Csaba Rácz, Lucian‐Cristian Pop, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 6854-6854
Open Access | Times Cited: 50
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 49
A critical review of bioactive glasses and glass–ceramics in cancer therapy
Ali Moeini, Turan Hassanzadeh Chinijani, Adrine Malek Khachatourian, et al.
International Journal of Applied Glass Science (2022) Vol. 14, Iss. 1, pp. 69-87
Open Access | Times Cited: 47
How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
Yaseen Hussain, Haroon Khan, Ghallab Alotaibi, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4058-4058
Open Access | Times Cited: 41
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top